Literature DB >> 15380587

Radiation response: an additional unique signature of myxoid liposarcoma.

Graham Pitson1, Philip Robinson, Derek Wilke, Rita A Kandel, Larry White, Anthony M Griffin, Robert S Bell, Charles N Catton, Jay S Wunder, Brian O'Sullivan.   

Abstract

PURPOSE: Historically, myxoid liposarcoma (MLS) has been reported to show a marked clinical response to radiotherapy (RT), but objective data to support that contention have been lacking. We performed a retrospective analysis of the response of a group of MLS tumors to preoperative RT using tumor dimensions calculated from pretreatment imaging and the subsequent surgical specimen obtained approximately 1 month after RT. METHODS AND MATERIALS: Data were abstracted from the Princess Margaret Hospital prospective database on a series of patients with MLS who had undergone preoperative RT between 1991 and 1999. A group of malignant fibrous histiocytoma (MFH) patients treated on the same protocol served as controls. Pretreatment and posttreatment three-dimensional measurements were obtained; comparison tumor volume measurements were estimated using the ellipsoid formula, and the analysis was also repeated using the maximal tumor dimension. Identical measurement procedures were used for the MLS (experimental) and MFH (control) cases.
RESULTS: A total of 16 MLS tumor specimens were available for analysis, and 16 MFH cases were randomly chosen for comparison. The mean pretreatment and posttreatment volume of the MLS tumors was 415 and 199 cm(3), respectively (P = <0.0001). The mean pretreatment and posttreatment volume of the MFH tumors was 264 and 273 cm(3), respectively (p = 0.804). The proportional reduction in the median tumor volume was 59% and -7% for MLS and MFH tumors, respectively. Both the absolute and the proportional reduction in volume for MLS tumors vs. MFH tumors was statistically significant (p = 0.006 and p = 0.002, respectively).
CONCLUSION: These results provide the first objective data to support the idea that MLS tumors show a statistically significant reduction in size when treated with RT and that this response is greater than that of MFH tumors given the same RT. These results may be relevant to the management of MLS with combined RT and surgery in difficult anatomic situations in which adequate surgical excision is not feasible. They also confirm another unique characteristic of this unusual subtype of soft tissue sarcoma.

Entities:  

Mesh:

Year:  2004        PMID: 15380587     DOI: 10.1016/j.ijrobp.2004.03.009

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  46 in total

1.  Neoadjuvant radiation in primary extremity liposarcoma: correlation of MRI features with histopathology.

Authors:  Jeremy R Wortman; Sree Harsha Tirumani; Harika Tirumani; Atul B Shinagare; Jyothi P Jagannathan; Jason L Hornick; Nikhil H Ramaiya
Journal:  Eur Radiol       Date:  2015-08-28       Impact factor: 5.315

2.  The RNA-binding protein fused in sarcoma (FUS) functions downstream of poly(ADP-ribose) polymerase (PARP) in response to DNA damage.

Authors:  Adam S Mastrocola; Sang Hwa Kim; Anthony T Trinh; Lance A Rodenkirch; Randal S Tibbetts
Journal:  J Biol Chem       Date:  2013-07-05       Impact factor: 5.157

Review 3.  Molecular Predictors of Radiotherapy Response in Sarcoma.

Authors:  Carlos H F Chan; Philip Wong
Journal:  Curr Treat Options Oncol       Date:  2016-01

4.  The enigma of myxofibrosarcoma of the extremity.

Authors:  Robert W Mutter; Samuel Singer; Zhigang Zhang; Murray F Brennan; Kaled M Alektiar
Journal:  Cancer       Date:  2011-06-29       Impact factor: 6.860

Review 5.  Liposarcoma: Multimodality Management and Future Targeted Therapies.

Authors:  Aimee M Crago; Mark A Dickson
Journal:  Surg Oncol Clin N Am       Date:  2016-07-30       Impact factor: 3.495

6.  Phase I trial of neoadjuvant conformal radiotherapy plus sorafenib for patients with locally advanced soft tissue sarcoma of the extremity.

Authors:  Robert J Canter; Dariusz Borys; Abimbola Olusanya; Chin-Shang Li; Li-Yuan Lee; Robert D Boutin; Scott D Christensen; Robert M Tamurian; Arta M Monjazeb
Journal:  Ann Surg Oncol       Date:  2014-02-20       Impact factor: 5.344

7.  Added Value of Molecular Biological Analysis in Diagnosis and Clinical Management of Liposarcoma: A 30-Year Single-Institution Experience.

Authors:  Ronald S A de Vreeze; Daphne de Jong; Petra M Nederlof; Aafke Ariaens; Ivon H G Tielen; Luc Frenken; Rick L Haas; Frits van Coevorden
Journal:  Ann Surg Oncol       Date:  2010-03       Impact factor: 5.344

8.  Radiographic and histologic response to neoadjuvant radiotherapy in patients with soft tissue sarcoma.

Authors:  Robert J Canter; Steve R Martinez; Robert M Tamurian; Maaya Wilton; Chin-Shang Li; Janice Ryu; Walter Mak; Wayne L Monsky; Dariusz Borys
Journal:  Ann Surg Oncol       Date:  2010-06-17       Impact factor: 5.344

9.  Volume changes in soft tissue sarcomas during preoperative radiotherapy of extremities evaluated using cone-beam CT.

Authors:  Anja Betgen; Rick L M Haas; Jan-Jakob Sonke
Journal:  J Radiat Oncol       Date:  2013-01-04

Review 10.  Surgical considerations when reporting MRI studies of soft tissue sarcoma of the limbs.

Authors:  Marcela De La Hoz Polo; Elizabeth Dick; Rej Bhumbra; Rob Pollock; Ranbir Sandhu; Asif Saifuddin
Journal:  Skeletal Radiol       Date:  2017-09-07       Impact factor: 2.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.